| 1 | Iminoglycinuria | Enrichment | SLC36A2, SLC6A18, SLC6A19, SLC6A20 | 8.59 |
| 2 | Genetic steroid-resistant nephrotic syndrome | Enrichment | NUP107, NUP133, NUP160, NUP205, NUP37, NUP85, NUP93 | 8.42 |
| 3 | Hyperinsulinemic hypoglycemia, familial, 1 | Enrichment | ABCC8, GCK, KCNJ11 | 4.48 |
| 4 | Nonsyndromic genetic hyperinsulinism | Enrichment | ABCC8, GCK, KCNJ11 | 4.48 |
| 5 | Nephrocalcinosis | Enrichment | SLC12A1, SLC34A1, SLC3A1 | 4.37 |
| 6 | Nephrolithiasis | Enrichment | SLC12A1, SLC34A1, SLC3A1 | 4.37 |
| 7 | Hyperglycinuria | Enrichment | SLC36A2, SLC6A19 | 4.29 |
| 8 | Hypophosphatemic rickets with hypercalciuria, hereditary | Enrichment | SLC34A1, SLC34A3 | 4.29 |
| 9 | Nephrolithiasis/osteoporosis, hypophosphatemic, 1 | Enrichment | SLC34A1, SLC34A3 | 4.29 |
| 10 | Myasthenic syndrome, congenital, 20, presynaptic | Enrichment | SLC22A5, SLC5A7 | 4.29 |
| 11 | Familial renal hypouricemia | Enrichment | SLC22A12, SLC2A9 | 4.29 |
| 12 | Permanent neonatal diabetes mellitus | Enrichment | ABCC8, GCK, KCNJ11 | 4.04 |
| 13 | Coronary heart disease 5 | Enrichment | ABCA1, ABCG5, ABCG8 | 3.87 |
| 14 | Cholestasis, progressive familial intrahepatic, 3 | Enrichment | ABCB11, ABCB4 | 3.84 |
| 15 | Gallbladder disease 4 | Enrichment | ABCG5, ABCG8 | 3.84 |
| 16 | Diabetes mellitus, permanent neonatal, 1 | Enrichment | GCK, KCNJ11 | 3.84 |
| 17 | Cholestasis, intrahepatic, of pregnancy 3 | Enrichment | ABCB11, ABCB4 | 3.84 |
| 18 | Intrahepatic cholestasis | Enrichment | ABCB11, ABCB4 | 3.84 |
| 19 | Hyperbilirubinemia, rotor type | Enrichment | SLCO1B1, SLCO1B3 | 3.81 |
| 20 | Cystinuria | Enrichment | SLC3A1, SLC7A9 | 3.51 |
| 21 | Renal glucosuria | Enrichment | SLC5A1, SLC5A2 | 3.51 |
| 22 | Familial infantile bilateral striatal necrosis | Enrichment | NUP54, NUP62 | 3.51 |
| 23 | Sitosterolemia 1 | Enrichment | ABCG5, ABCG8 | 3.37 |
| 24 | Hypoalphalipoproteinemia, primary, 2 | Enrichment | ABCA1, APOA1 | 3.37 |
| 25 | Sitosterolemia | Enrichment | ABCG5, ABCG8 | 3.37 |
| 26 | Dend syndrome | Enrichment | ABCC8, KCNJ11 | 3.37 |
| 27 | Hypoalphalipoproteinemia, primary, 1 | Enrichment | ABCA1, APOA1 | 3.07 |
| 28 | Neonatal diabetes mellitus | Enrichment | ABCC8, KCNJ11 | 3.07 |
| 29 | Intrahepatic cholestasis of pregnancy | Enrichment | ABCB11, ABCB4 | 3.07 |
| 30 | Bartter disease | Enrichment | SLC12A1, SLC12A3 | 2.97 |
| 31 | Transient neonatal diabetes mellitus | Enrichment | ABCC8, KCNJ11 | 2.85 |
| 32 | Polyhydramnios | Enrichment | ABCC8, SLC26A3 | 2.85 |
| 33 | Hypoglycemia | Enrichment | ABCC8, KCNJ11 | 2.85 |
| 34 | Alternating hemiplegia of childhood | Enrichment | SLC1A3, SLC2A1 | 2.85 |
| 35 | Type 2 diabetes mellitus | Enrichment | ABCC8, GCK, KCNJ11, SLC2A2 | 2.80 |
| 36 | Maturity-onset diabetes of the young | Enrichment | ABCC8, GCK, KCNJ11 | 2.78 |
| 37 | Pseudoxanthoma elasticum | Enrichment | ABCC2, ABCC6 | 2.68 |
| 38 | Lipid metabolism disorder | Enrichment | ABCG5, ABCG8 | 2.68 |
| 39 | Patent ductus arteriosus | Enrichment | ABCC9, PSMC3 | 2.68 |
| 40 | Galloway-mowat syndrome | Enrichment | NUP107, NUP133 | 2.65 |
| 41 | Progressive familial intrahepatic cholestasis | Enrichment | ABCB11, ABCB4 | 2.54 |
| 42 | Methylmalonic aciduria and homocystinuria, cblc type | Enrichment | ABCD4, LMBRD1 | 2.42 |
| 43 | Homozygous familial hypercholesterolemia | Enrichment | ABCG5, ABCG8 | 2.42 |
| 44 | Diabetes insipidus, neurohypophyseal | Enrichment | AVP | 2.14 |
| 45 | Neuronopathy, distal hereditary motor, autosomal dominant 7 | Enrichment | SLC5A7 | 2.14 |
| 46 | Skin/hair/eye pigmentation, variation in, 6 | Enrichment | SLC24A4 | 2.14 |
| 47 | Acrodermatitis enteropathica, zinc-deficiency type | Enrichment | SLC39A4 | 2.14 |
| 48 | Diastrophic dysplasia | Enrichment | SLC26A2 | 2.14 |
| 49 | Overhydrated hereditary stomatocytosis | Enrichment | RHAG | 2.14 |
| 50 | Hypouricemia, renal, 1 | Enrichment | SLC22A12 | 2.14 |
| 51 | Anemia, congenital, nonspherocytic hemolytic, 5 | Enrichment | HK1 | 2.14 |
| 52 | Dicarboxylic aminoaciduria | Enrichment | SLC1A1 | 2.14 |
| 53 | Pulmonary alveolar microlithiasis | Enrichment | SLC34A2 | 2.14 |
| 54 | Rh-null, regulator type | Enrichment | RHAG | 2.14 |
| 55 | Thyroid dyshormonogenesis 1 | Enrichment | SLC5A5 | 2.14 |
| 56 | Intellectual developmental disorder, x-linked, syndromic, christianson type | Enrichment | SLC9A6 | 2.14 |
| 57 | Nephrogenic syndrome of inappropriate antidiuresis | Enrichment | AVPR2 | 2.14 |
| 58 | Congenital disorder of glycosylation, type iim | Enrichment | SLC35A2 | 2.14 |
| 59 | Diabetes insipidus, nephrogenic, 1, x-linked | Enrichment | AVPR2 | 2.14 |
| 60 | Congenital disorder of glycosylation, type iic | Enrichment | SLC35C1 | 2.14 |
| 61 | Atelosteogenesis, type ii | Enrichment | SLC26A2 | 2.14 |
| 62 | Blood group, diego system | Enrichment | SLC4A1 | 2.14 |
| 63 | Aceruloplasminemia | Enrichment | CP | 2.14 |
| 64 | Ovalocytosis, southeast asian | Enrichment | SLC4A1 | 2.14 |
| 65 | Stomatin-deficient cryohydrocytosis with neurologic defects | Enrichment | SLC2A1 | 2.14 |
| 66 | Spastic paraplegia 42, autosomal dominant | Enrichment | SLC33A1 | 2.14 |
| 67 | Hypertrophic osteoarthropathy, primary, autosomal dominant | Enrichment | SLCO2A1 | 2.14 |
| 68 | Blood group--wright antigen | Enrichment | SLC4A1 | 2.14 |
| 69 | Spherocytosis, type 4 | Enrichment | SLC4A1 | 2.14 |
| 70 | Episodic ataxia, type 6 | Enrichment | SLC1A3 | 2.14 |
| 71 | Maturity-onset diabetes of the young, type 2 | Enrichment | GCK | 2.14 |
| 72 | Epiphyseal dysplasia, multiple, 4 | Enrichment | SLC26A2 | 2.14 |
| 73 | Erythrocyte lactate transporter defect | Enrichment | SLC16A1 | 2.14 |
| 74 | Diarrhea 1, secretory chloride, congenital | Enrichment | SLC26A3 | 2.14 |
| 75 | Fanconi renotubular syndrome 2 | Enrichment | SLC34A1 | 2.14 |
| 76 | Retinitis pigmentosa 79 | Enrichment | HK1 | 2.14 |
| 77 | Cryohydrocytosis | Enrichment | SLC4A1 | 2.14 |
| 78 | Anemia, hypochromic microcytic, with iron overload 1 | Enrichment | SLC11A2 | 2.14 |
| 79 | Fetal akinesia deformation sequence 4 | Enrichment | NUP88 | 2.14 |
| 80 | Schizophrenia 18 | Enrichment | SLC1A1 | 2.14 |
| 81 | Neurodevelopmental disorder with achalasia, polyneuropathy, and alacrima | Enrichment | NDC1 | 2.14 |
| 82 | Blood group--swann system | Enrichment | SLC4A1 | 2.14 |
| 83 | Atrial fibrillation, familial, 15 | Enrichment | NUP155 | 2.14 |
| 84 | Dystonia 37, early-onset, with striatal lesions | Enrichment | NUP54 | 2.14 |
| 85 | Nephrotic syndrome, type 19 | Enrichment | NUP160 | 2.14 |
| 86 | Rhabdomyosarcoma, embryonal, 1 | Enrichment | SLC67A1 | 2.14 |
| 87 | Neurodegenerative disorder, x-linked, female-restricted, with parkinsonism and cognitive impairment | Enrichment | SLC9A6 | 2.14 |
| 88 | Acrodermatitis enteropathica | Enrichment | SLC39A4 | 2.14 |
| 89 | Glucose/galactose malabsorption | Enrichment | SLC5A1 | 2.14 |
| 90 | Galloway-mowat syndrome 8 | Enrichment | NUP133 | 2.14 |
| 91 | Achondrogenesis, type ib | Enrichment | SLC26A2 | 2.14 |
| 92 | Nephrotic syndrome, type 13 | Enrichment | NUP205 | 2.14 |
| 93 | Central diabetes insipidus | Enrichment | AVP | 2.14 |
| 94 | Hypercalcemia, infantile, 2 | Enrichment | SLC34A1 | 2.14 |
| 95 | Autism 16 | Enrichment | SLC9A9 | 2.14 |
| 96 | X-linked nephrogenic diabetes insipidus | Enrichment | AVPR2 | 2.14 |
| 97 | Hemochromatosis, type 4 | Enrichment | SLC40A1 | 2.14 |
| 98 | Hyperinsulinemic hypoglycemia, familial, 3 | Enrichment | GCK | 2.14 |
| 99 | Amelogenesis imperfecta, hypomaturation type, iia5 | Enrichment | SLC24A4 | 2.14 |
| 100 | Congenital disorder of glycosylation, type iif | Enrichment | SLC35A1 | 2.14 |
| 101 | Neuropathy, hereditary motor and sensory, russe type | Enrichment | HK1 | 2.14 |
| 102 | Deafness, autosomal dominant 25 | Enrichment | SLC17A8 | 2.14 |
| 103 | Microcephaly 24, primary, autosomal recessive | Enrichment | NUP37 | 2.14 |
| 104 | Parkinsonism-dystonia 1, infantile-onset | Enrichment | SLC6A3 | 2.14 |
| 105 | Galloway-mowat syndrome 7 | Enrichment | NUP107 | 2.14 |
| 106 | Neurodevelopmental disorder with visual defects and brain anomalies | Enrichment | HK1 | 2.14 |
| 107 | Ichthyosis prematurity syndrome | Enrichment | SLC27A4 | 2.14 |
| 108 | Huppke-brendel syndrome | Enrichment | SLC33A1 | 2.14 |
| 109 | Epilepsy, idiopathic generalized 12 | Enrichment | SLC2A1 | 2.14 |
| 110 | Night blindness, congenital stationary, type 1d | Enrichment | SLC24A1 | 2.14 |
| 111 | Nephrotic syndrome, type 12 | Enrichment | NUP93 | 2.14 |
| 112 | Arthrogryposis, impaired intellectual development, and seizures | Enrichment | SLC35A3 | 2.14 |
| 113 | Hyperekplexia 3 | Enrichment | SLC6A5 | 2.14 |
| 114 | Fasting plasma glucose level quantitative trait locus 5 | Enrichment | GCKR | 2.14 |
| 115 | Nephrotic syndrome, type 11 | Enrichment | NUP107 | 2.14 |
| 116 | Encephalopathy, acute, infection-induced 9 | Enrichment | NUP214 | 2.14 |
| 117 | Sandestig-stefanova syndrome | Enrichment | NUP188 | 2.14 |
| 118 | Chronic enteropathy associated with slco2a1 gene | Enrichment | SLCO2A1 | 2.14 |
| 119 | Ovarian dysgenesis 6 | Enrichment | NUP107 | 2.14 |
| 120 | Intellectual developmental disorder, autosomal recessive 79 | Enrichment | TPR | 2.14 |
| 121 | Nephrotic syndrome, type 18 | Enrichment | NUP133 | 2.14 |
| 122 | Postural orthostatic tachycardia syndrome | Enrichment | SLC6A2 | 2.14 |
| 123 | Autosomal recessive hypophosphatemic bone disease | Enrichment | SLC34A3 | 2.14 |
| 124 | Classic dopamine transporter deficiency syndrome | Enrichment | SLC6A3 | 2.14 |
| 125 | Hot water epilepsy | Enrichment | SLC1A1 | 2.14 |
| 126 | Gestational diabetes | Enrichment | GCK | 2.14 |
| 127 | Epilepsy with myoclonic absences | Enrichment | SLC2A1 | 2.14 |
| 128 | Familial acute necrotizing encephalopathy | Enrichment | RANBP2 | 2.14 |
| 129 | Isolated focal cortical dysplasia type ia | Enrichment | SLC35A2 | 2.14 |
| 130 | Parkinsonism-dystonia, infantile | Enrichment | SLC6A3 | 2.14 |
| 131 | Hereditary cryohydrocytosis with reduced stomatin | Enrichment | SLC2A1 | 2.14 |
| 132 | Hereditary arginine vasopressin deficiency | Enrichment | AVP | 2.14 |
| 133 | Diabetes mellitus | Enrichment | GCK, KCNJ11 | 2.13 |
| 134 | Methylmalonic aciduria and homocystinuria, cblf type | Enrichment | LMBRD1 | 1.92 |
| 135 | Hyperinsulinemic hypoglycemia, familial, 2 | Enrichment | KCNJ11 | 1.92 |
| 136 | Spastic paraplegia 18b, autosomal recessive | Enrichment | ERLIN2 | 1.92 |
| 137 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1 | Enrichment | VCP | 1.92 |
| 138 | Dyschromatosis universalis hereditaria 3 | Enrichment | ABCB6 | 1.92 |
| 139 | Blood group, langereis system | Enrichment | ABCB6 | 1.92 |
| 140 | Arterial calcification, generalized, of infancy, 2 | Enrichment | ABCC6 | 1.92 |
| 141 | Hypoadrenocorticism, familial | Enrichment | ABCD1 | 1.92 |
| 142 | Microphthalmia/coloboma 7 | Enrichment | ABCB6 | 1.92 |
| 143 | Pseudoxanthoma elasticum, forme fruste | Enrichment | ABCC6 | 1.92 |
| 144 | Gallbladder disease 1 | Enrichment | ABCB4 | 1.92 |
| 145 | Intellectual disability and myopathy syndrome | Enrichment | ABCC9 | 1.92 |
| 146 | Neurodevelopmental disorder with microcephaly, hypotonia, and absent language | Enrichment | PSMB1 | 1.92 |
| 147 | Maturity-onset diabetes of the young, type 12 | Enrichment | ABCC8 | 1.92 |
| 148 | Stankiewicz-isidor syndrome | Enrichment | PSMD12 | 1.92 |
| 149 | Dyschromatosis universalis hereditaria | Enrichment | ABCB6 | 1.92 |
| 150 | Diabetes mellitus, transient neonatal, 3 | Enrichment | KCNJ11 | 1.92 |
| 151 | Pseudohyperkalemia, familial, 2, due to red cell leak | Enrichment | ABCB6 | 1.92 |
| 152 | Deafness, cataract, impaired intellectual development, and polyneuropathy | Enrichment | PSMC3 | 1.92 |
| 153 | Hereditary spastic paraplegia 18 | Enrichment | ERLIN2 | 1.92 |
| 154 | Diabetes mellitus, permanent neonatal, 2 | Enrichment | KCNJ11 | 1.92 |
| 155 | Methylmalonic aciduria and homocystinuria, cblj type | Enrichment | ABCD4 | 1.92 |
| 156 | Maturity-onset diabetes of the young, type 13 | Enrichment | KCNJ11 | 1.92 |
| 157 | Encephalitis | Enrichment | ABCD1 | 1.92 |
| 158 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 | Enrichment | VCP | 1.92 |
| 159 | Autosomal dominant hyperinsulinism due to sur1 deficiency | Enrichment | ABCC8 | 1.92 |
| 160 | Neurodevelopmental disorder with poor growth, absent speech, progressive ataxia, and dysmorphic facies | Enrichment | SEL1L | 1.92 |
| 161 | Multisystem proteinopathy | Enrichment | VCP | 1.92 |
| 162 | Primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies | Enrichment | ABCA3 | 1.92 |
| 163 | Spastic paraplegia 62, autosomal recessive | Enrichment | ERLIN1 | 1.92 |
| 164 | X-linked cerebral adrenoleukodystrophy | Enrichment | ABCD1 | 1.92 |
| 165 | Adult-onset distal myopathy due to vcp mutation | Enrichment | VCP | 1.92 |
| 166 | Diazoxide-resistant focal hyperinsulinism due to sur1 deficiency | Enrichment | ABCC8 | 1.92 |
| 167 | Spastic paraplegia 18a, autosomal dominant | Enrichment | ERLIN2 | 1.92 |
| 168 | Aquagenic palmoplantar keratoderma | Enrichment | CFTR | 1.92 |
| 169 | Congestive heart failure | Enrichment | ABCC8 | 1.92 |
| 170 | Intermediate dend syndrome | Enrichment | KCNJ11 | 1.92 |
| 171 | Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome | Enrichment | ERLIN2 | 1.92 |
| 172 | Adrenomyeloneuropathy | Enrichment | ABCD1 | 1.92 |
| 173 | Diazoxide-resistant focal hyperinsulinism due to kir6.2 deficiency | Enrichment | KCNJ11 | 1.92 |
| 174 | Chronic primary adrenal insufficiency | Enrichment | ABCD1 | 1.92 |
| 175 | Autosomal recessive hyperinsulinism due to sur1 deficiency | Enrichment | ABCC8 | 1.92 |
| 176 | Hypoalphalipoproteinemia | Enrichment | ABCA1 | 1.92 |
| 177 | Autosomal dominant hyperinsulinism due to kir6.2 deficiency | Enrichment | KCNJ11 | 1.92 |
| 178 | Autosomal recessive hyperinsulinism due to kir6.2 deficiency | Enrichment | KCNJ11 | 1.92 |
| 179 | Autosomal recessive congenital ichthyosis | Enrichment | ABCA12, SLC27A4 | 1.87 |
| 180 | Maturity-onset diabetes of the young, type 1 | Enrichment | GCK | 1.84 |
| 181 | Fanconi-bickel syndrome | Enrichment | SLC2A2 | 1.84 |
| 182 | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | Enrichment | TPR | 1.84 |
| 183 | Striatonigral degeneration, infantile | Enrichment | NUP62 | 1.84 |
| 184 | Dystonia 9 | Enrichment | SLC2A1 | 1.84 |
| 185 | Histiocytosis-lymphadenopathy plus syndrome | Enrichment | SLC29A3 | 1.84 |
| 186 | 3mc syndrome 2 | Enrichment | SLC26A2 | 1.84 |
| 187 | Glut1 deficiency syndrome 1 | Enrichment | SLC2A1 | 1.84 |
| 188 | Proximal renal tubular acidosis-ocular anomaly syndrome | Enrichment | SLC4A4 | 1.84 |
| 189 | Albinism, oculocutaneous, type vi | Enrichment | SLC24A5 | 1.84 |
| 190 | Bone marrow failure syndrome 2 | Enrichment | GCK | 1.84 |
| 191 | Hypouricemia, renal, 2 | Enrichment | SLC2A9 | 1.84 |
| 192 | Monocarboxylate transporter 1 deficiency | Enrichment | SLC16A1 | 1.84 |
| 193 | Myasthenic syndrome, congenital, 22 | Enrichment | SLC3A1 | 1.84 |
| 194 | Hartnup disorder | Enrichment | SLC6A19 | 1.84 |
| 195 | Factor xii deficiency | Enrichment | SLC34A1 | 1.84 |
| 196 | Phoar2-enteropathy syndrome | Enrichment | SLCO2A1 | 1.84 |
| 197 | Hermansky-pudlak syndrome 3 | Enrichment | CP | 1.84 |
| 198 | Bartter syndrome, type 1, antenatal | Enrichment | SLC12A1 | 1.84 |
| 199 | Nephrotic syndrome, type 17 | Enrichment | NUP85 | 1.84 |
| 200 | Glucose transporter type 1 deficiency syndrome | Enrichment | SLC2A1 | 1.84 |
| 201 | Renal tubular acidosis | Enrichment | SLC4A1 | 1.84 |
| 202 | Primary hypertrophic osteoarthropathy | Enrichment | SLCO2A1 | 1.84 |
| 203 | Hyperinsulinemic hypoglycemia, familial, 7 | Enrichment | SLC16A1 | 1.84 |
| 204 | Renal tubular acidosis, distal, 4, with hemolytic anemia | Enrichment | SLC4A1 | 1.84 |
| 205 | Autosomal recessive infantile hypercalcemia | Enrichment | SLC34A1 | 1.84 |
| 206 | Distal hereditary motor neuropathy type 7 | Enrichment | SLC5A7 | 1.84 |
| 207 | Acute myeloid leukemia with t(6;9) (p23;q34.1) | Enrichment | NUP214 | 1.84 |
| 208 | Autosomal recessive proximal renal tubular acidosis | Enrichment | SLC4A4 | 1.84 |
| 209 | Ketoacidosis due to monocarboxylate transporter-1 deficiency | Enrichment | SLC16A1 | 1.84 |
| 210 | Dominant hypophosphatemia with nephrolithiasis or osteoporosis | Enrichment | SLC34A1 | 1.84 |
| 211 | Acute necrotizing encephalopathy of childhood | Enrichment | RANBP2 | 1.84 |
| 212 | Hypokalemia | Enrichment | SLC12A3 | 1.84 |
| 213 | Intestinal obstruction | Enrichment | SLC26A3 | 1.84 |
| 214 | Wolff-parkinson-white syndrome | Enrichment | ABCC9, SLC26A4 | 1.81 |
| 215 | Neuropathy, hereditary motor and sensory, okinawa type | Enrichment | SLC5A7, VCP | 1.67 |
| 216 | Night blindness, congenital stationary, autosomal dominant 2 | Enrichment | SLC24A1 | 1.67 |
| 217 | Arterial tortuosity syndrome | Enrichment | SLC2A10 | 1.67 |
| 218 | Agenesis of the corpus callosum with peripheral neuropathy | Enrichment | SLC12A6 | 1.67 |
| 219 | Lysinuric protein intolerance | Enrichment | SLC7A7 | 1.67 |
| 220 | Nijmegen breakage syndrome | Enrichment | GCK | 1.67 |
| 221 | Dysosteosclerosis | Enrichment | SLC29A3 | 1.67 |
| 222 | Carnitine deficiency, systemic primary | Enrichment | SLC22A5 | 1.67 |
| 223 | Glut1 deficiency syndrome 2 | Enrichment | SLC2A1 | 1.67 |
| 224 | Hypotonia-cystinuria syndrome | Enrichment | SLC3A1 | 1.67 |
| 225 | Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive | Enrichment | RANBP2 | 1.67 |
| 226 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1 | Enrichment | SLCO2A1 | 1.67 |
| 227 | Charcot-marie-tooth disease, axonal, type 2ii | Enrichment | SLC12A6 | 1.67 |
| 228 | Chromosome 17q23.1-q23.2 deletion syndrome | Enrichment | SLC2A1 | 1.67 |
| 229 | Familial renal glucosuria | Enrichment | SLC5A2 | 1.67 |
| 230 | Nephrogenic diabetes insipidus | Enrichment | AVPR2 | 1.67 |
| 231 | Hemolytic disease of fetus and newborn, rh-induced | Enrichment | RHAG | 1.67 |
| 232 | Atypical hypotonia-cystinuria syndrome | Enrichment | SLC3A1 | 1.67 |
| 233 | Ichthyosis, congenital, autosomal recessive 4b | Enrichment | ABCA12 | 1.62 |
| 234 | Carbamoyl phosphate synthetase i deficiency, hyperammonemia due to | Enrichment | ABCA3 | 1.62 |
| 235 | Tangier disease | Enrichment | ABCA1 | 1.62 |
| 236 | Spondyloepimetaphyseal dysplasia, x-linked | Enrichment | ABCD1 | 1.62 |
| 237 | Spermatogenic failure, y-linked, 2 | Enrichment | CFTR | 1.62 |
| 238 | Surfactant metabolism dysfunction, pulmonary, 1 | Enrichment | ABCA3 | 1.62 |
| 239 | Adrenoleukodystrophy | Enrichment | ABCD1 | 1.62 |
| 240 | Ichthyosis, congenital, autosomal recessive 4a | Enrichment | ABCA12 | 1.62 |
| 241 | Cardiomyopathy, dilated, 1o | Enrichment | ABCC9 | 1.62 |
| 242 | Amyotrophic lateral sclerosis 6 with or without frontotemporal dementia | Enrichment | VCP | 1.62 |
| 243 | Cholestasis, benign recurrent intrahepatic, 2 | Enrichment | ABCB11 | 1.62 |
| 244 | Primary lateral sclerosis, juvenile | Enrichment | ERLIN2 | 1.62 |
| 245 | Hypoglycemia, leucine-induced | Enrichment | ABCC8 | 1.62 |
| 246 | Cholestasis, progressive familial intrahepatic, 4 | Enrichment | ABCB11 | 1.62 |
| 247 | Atrial fibrillation, familial, 12 | Enrichment | ABCC9 | 1.62 |
| 248 | Diabetes mellitus, transient neonatal, 2 | Enrichment | ABCC8 | 1.62 |
| 249 | Cholestasis, progressive familial intrahepatic, 2 | Enrichment | ABCB11 | 1.62 |
| 250 | Birk-aharoni syndrome | Enrichment | PSMC1 | 1.62 |
| 251 | Sitosterolemia 2 | Enrichment | ABCG5 | 1.62 |
| 252 | Proteasome-associated autoinflammatory syndrome 3 | Enrichment | PSMB4 | 1.62 |
| 253 | Surfactant metabolism dysfunction, pulmonary, 3 | Enrichment | ABCA3 | 1.62 |
| 254 | Short-rib thoracic dysplasia 15 with polydactyly | Enrichment | ABCG5 | 1.62 |
| 255 | Diabetes mellitus, permanent neonatal, 3 | Enrichment | ABCC8 | 1.62 |
| 256 | 17q24.2 microdeletion syndrome | Enrichment | PSMD12 | 1.62 |
| 257 | Hypoalphalipoproteinemia, primary, 2, intermediate | Enrichment | APOA1 | 1.62 |
| 258 | Amyloidosis, hereditary systemic 3 | Enrichment | APOA1 | 1.62 |
| 259 | Arterial calcification of infancy | Enrichment | ABCC6 | 1.62 |
| 260 | Cadds | Enrichment | ABCD1 | 1.62 |
| 261 | Hyperinsulinism | Enrichment | KCNJ11 | 1.62 |
| 262 | Neurodevelopmental disorder with hypotonia, poor growth, dysmorphic facies, and agammaglobulinemia | Enrichment | SEL1L | 1.62 |
| 263 | Submucosal cleft palate | Enrichment | UBB | 1.62 |
| 264 | Cleft hard palate | Enrichment | UBB | 1.62 |
| 265 | Spastic paraplegia-paget disease of bone syndrome | Enrichment | VCP | 1.62 |
| 266 | Amelogenesis imperfecta, type iiia | Enrichment | SLC24A4 | 1.54 |
| 267 | Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema | Enrichment | SLC4A1 | 1.54 |
| 268 | Ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive | Enrichment | RANBP2 | 1.54 |
| 269 | Achalasia-addisonianism-alacrima syndrome | Enrichment | AAAS | 1.54 |
| 270 | Infantile sialic acid storage disease | Enrichment | SLC17A5 | 1.54 |
| 271 | Maturity-onset diabetes of the young, type 3 | Enrichment | GCK | 1.54 |
| 272 | Salla disease | Enrichment | SLC17A5 | 1.54 |
| 273 | Tobacco addiction | Enrichment | SLC6A3 | 1.54 |
| 274 | Basal ganglia calcification | Enrichment | SLC20A2 | 1.54 |
| 275 | Ectodermal dysplasia | Enrichment | RANBP2 | 1.54 |
| 276 | Embryonal rhabdomyosarcoma | Enrichment | SLC67A1 | 1.54 |
| 277 | Diabetes insipidus | Enrichment | AVP | 1.54 |
| 278 | 2p21 microdeletion syndrome | Enrichment | SLC3A1 | 1.54 |
| 279 | Primary fanconi renotubular syndrome | Enrichment | SLC34A1 | 1.54 |
| 280 | Familial atrial fibrillation | Enrichment | ABCC9, NUP155 | 1.48 |
| 281 | Ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant | Enrichment | RANBP2 | 1.45 |
| 282 | Gitelman syndrome | Enrichment | SLC12A3 | 1.45 |
| 283 | Deafness, autosomal recessive 4, with enlarged vestibular aqueduct | Enrichment | SLC26A4 | 1.45 |
| 284 | Hyperekplexia | Enrichment | SLC6A5 | 1.45 |
| 285 | Autosomal recessive hypohidrotic ectodermal dysplasia syndrome | Enrichment | RANBP2 | 1.45 |
| 286 | Free sialic acid storage disorder | Enrichment | SLC17A5 | 1.45 |
| 287 | Sleep disorder | Enrichment | SLC9A6 | 1.45 |
| 288 | Prognathism, mandibular | Enrichment | ERLEC1 | 1.45 |
| 289 | Dubin-johnson syndrome | Enrichment | ABCC2 | 1.45 |
| 290 | Cantu syndrome | Enrichment | ABCC9 | 1.45 |
| 291 | Proteasome-associated autoinflammatory syndrome 1 | Enrichment | PSMB4 | 1.45 |
| 292 | Uvula, bifid | Enrichment | UBB | 1.45 |
| 293 | Nuchal bleb, familial | Enrichment | CFTR | 1.45 |
| 294 | Cleft soft palate | Enrichment | UBB | 1.45 |
| 295 | Ehlers-danlos syndrome, kyphoscoliotic type, 1 | Enrichment | ABCD1 | 1.45 |
| 296 | Inclusion body myopathy with paget disease of bone and frontotemporal dementia | Enrichment | VCP | 1.45 |
| 297 | Proteosome-associated autoinflammatory syndrome | Enrichment | PSMB4 | 1.45 |
| 298 | Hyperinsulinemic hypoglycemia | Enrichment | ABCC8 | 1.45 |
| 299 | Spastic paraplegia 50, autosomal recessive | Enrichment | APOA1 | 1.45 |
| 300 | Plod1-related kyphoscoliotic ehlers-danlos syndrome | Enrichment | ABCD1 | 1.45 |
| 301 | Pediatric acute respiratory distress syndrome | Enrichment | ABCA3 | 1.45 |
| 302 | Thyroid hemiagenesis | Enrichment | PSMD3 | 1.45 |
| 303 | Congenital nervous system abnormality | Enrichment | AAAS, ABCD1, ERLIN2, SLC22A5 | 1.41 |
| 304 | Nervous system disease | Enrichment | AAAS, ABCD1, ERLIN2, SLC22A5 | 1.41 |
| 305 | Renal tubular acidosis, distal, 1 | Enrichment | SLC4A1 | 1.37 |
| 306 | Pendred syndrome | Enrichment | SLC26A4 | 1.37 |
| 307 | Inflammatory myofibroblastic tumor | Enrichment | RANBP2 | 1.37 |
| 308 | Familial thyroid dyshormonogenesis | Enrichment | SLC5A5 | 1.37 |
| 309 | Hereditary spherocytosis | Enrichment | SLC4A1 | 1.37 |
| 310 | Breast adenocarcinoma | Enrichment | SLC67A1 | 1.37 |
| 311 | Autosomal recessive distal renal tubular acidosis | Enrichment | SLC4A1 | 1.37 |
| 312 | Distal renal tubular acidosis | Enrichment | SLC4A1 | 1.37 |
| 313 | Hirschsprung disease 1 | Enrichment | ABCD1, NUP98 | 1.33 |
| 314 | Dermatitis, atopic | Enrichment | KCNJ11 | 1.33 |
| 315 | Newborn respiratory distress syndrome | Enrichment | ABCC8 | 1.33 |
| 316 | Idiopathic bronchiectasis | Enrichment | CFTR | 1.33 |
| 317 | Eyelid coloboma | Enrichment | ABCB6 | 1.33 |
| 318 | Lens coloboma | Enrichment | ABCB6 | 1.33 |
| 319 | Mitochondrial dna depletion syndrome 4a | Enrichment | RANBP2 | 1.31 |
| 320 | Hypothyroidism, congenital, nongoitrous, 2 | Enrichment | SLC26A4 | 1.31 |
| 321 | Oculocutaneous albinism | Enrichment | SLC24A5 | 1.31 |
| 322 | Amelogenesis imperfecta type 2 | Enrichment | SLC24A4 | 1.31 |
| 323 | Paroxysmal dystonia | Enrichment | SLC2A1 | 1.31 |
| 324 | Cystic fibrosis | Enrichment | CFTR, SLC6A14 | 1.25 |
| 325 | Basal ganglia calcification, idiopathic, 1 | Enrichment | SLC20A2 | 1.25 |
| 326 | Orthostatic intolerance | Enrichment | SLC6A2 | 1.25 |
| 327 | Mitochondrial dna depletion syndrome 4b | Enrichment | RANBP2 | 1.25 |
| 328 | Hypothyroidism | Enrichment | SLC33A1 | 1.25 |
| 329 | Amyloidosis, hereditary systemic 2 | Enrichment | APOA1 | 1.23 |
| 330 | Dementia, lewy body | Enrichment | VCP | 1.23 |
| 331 | Charcot-marie-tooth disease, axonal, type 2e | Enrichment | VCP | 1.23 |
| 332 | Coloboma of choroid and retina | Enrichment | ABCB6 | 1.23 |
| 333 | Hereditary pulmonary alveolar proteinosis | Enrichment | ABCA3 | 1.23 |
| 334 | Myoclonic-atonic epilepsy | Enrichment | SLC2A1 | 1.20 |
| 335 | Hydrops fetalis | Enrichment | SLC26A3 | 1.20 |
| 336 | Neurodegeneration with brain iron accumulation | Enrichment | CP | 1.16 |
| 337 | Developmental dysplasia of the hip 1 | Enrichment | PSMC3 | 1.16 |
| 338 | Coloboma of optic nerve | Enrichment | ABCB6 | 1.16 |
| 339 | Cholestasis, progressive familial intrahepatic, 1 | Enrichment | ABCB4 | 1.16 |
| 340 | Kleefstra syndrome 1 | Enrichment | ABCC9 | 1.16 |
| 341 | Hypertrichosis | Enrichment | KCNJ11 | 1.16 |
| 342 | Gilbert syndrome | Enrichment | SLCO1B1 | 1.12 |
| 343 | Osteochondrodysplasia | Enrichment | SLC26A2 | 1.12 |
| 344 | Presynaptic congenital myasthenic syndromes | Enrichment | SLC5A7 | 1.12 |
| 345 | Congenital hypothyroidism | Enrichment | SLC5A5 | 1.08 |
| 346 | 46 xx gonadal dysgenesis | Enrichment | NUP107 | 1.08 |
| 347 | Congenital long qt syndrome | Enrichment | SLC2A2 | 1.08 |
| 348 | Amelogenesis imperfecta | Enrichment | SLC24A4 | 1.05 |
| 349 | Hereditary spastic paraplegia | Enrichment | ERLIN1, ERLIN2 | 1.04 |
| 350 | Gastroesophageal reflux | Enrichment | ABCC8 | 1.04 |
| 351 | Fanconi anemia, complementation group c | Enrichment | ABCC9 | 1.04 |
| 352 | Myocarditis | Enrichment | ABCD1 | 1.04 |
| 353 | Isolated split hand-split foot malformation | Enrichment | SEM1 | 1.04 |
| 354 | Seckel syndrome | Enrichment | NUP85 | 1.02 |
| 355 | Osteogenesis imperfecta, type iii | Enrichment | SLC34A1 | 0.99 |
| 356 | Hermansky-pudlak syndrome | Enrichment | CP | 0.99 |
| 357 | Bronchiectasis with or without elevated sweat chloride 1 | Enrichment | CFTR | 0.99 |
| 358 | Vas deferens, congenital bilateral aplasia of | Enrichment | CFTR | 0.99 |
| 359 | Loeys-dietz syndrome | Enrichment | ABCA3 | 0.99 |
| 360 | Progressive non-fluent aphasia | Enrichment | VCP | 0.99 |
| 361 | Behavioral variant of frontotemporal dementia | Enrichment | VCP | 0.99 |
| 362 | Juvenile amyotrophic lateral sclerosis | Enrichment | ERLIN1 | 0.99 |
| 363 | Hermansky-pudlak syndrome 1 | Enrichment | CP | 0.96 |
| 364 | Cat eye syndrome | Enrichment | ABCB6 | 0.94 |
| 365 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | Enrichment | VCP | 0.94 |
| 366 | Polymicrogyria | Enrichment | PSMC3 | 0.94 |
| 367 | Congenital nonbullous ichthyosiform erythroderma | Enrichment | ABCA12 | 0.94 |
| 368 | Congenital disorder of glycosylation, type in | Enrichment | SLC35A2 | 0.94 |
| 369 | Atrial heart septal defect | Enrichment | ABCC8 | 0.90 |
| 370 | Ichthyosis | Enrichment | ABCA12 | 0.90 |
| 371 | Interatrial communication | Enrichment | ABCC8 | 0.90 |
| 372 | Focal segmental glomerulosclerosis | Enrichment | NUP93 | 0.87 |
| 373 | Epicanthus | Enrichment | ABCC9 | 0.87 |
| 374 | Cutis laxa | Enrichment | ABCC6 | 0.87 |
| 375 | Cardiomyopathy, dilated, 1a | Enrichment | SLC22A5 | 0.85 |
| 376 | Alzheimer's disease | Enrichment | VCP | 0.84 |
| 377 | Tooth agenesis | Enrichment | RANBP2 | 0.83 |
| 378 | Malaria | Enrichment | SLC4A1 | 0.81 |
| 379 | Congenital stationary night blindness | Enrichment | SLC24A1 | 0.81 |
| 380 | Precursor t-cell acute lymphoblastic leukemia | Enrichment | NUP214 | 0.81 |
| 381 | Hereditary chronic pancreatitis | Enrichment | CFTR | 0.81 |
| 382 | Ear malformation | Enrichment | SLC26A4 | 0.80 |
| 383 | Autoinflammatory disease | Enrichment | SLC7A7 | 0.80 |
| 384 | Scoliosis | Enrichment | SLC9A6 | 0.80 |
| 385 | Developmental and epileptic encephalopathy 1 | Enrichment | SLC2A1 | 0.78 |
| 386 | Coloboma of macula | Enrichment | ABCB6 | 0.78 |
| 387 | Lynch syndrome | Enrichment | CFTR | 0.78 |
| 388 | Rasopathy | Enrichment | SLC26A4 | 0.76 |
| 389 | Auditory neuropathy | Enrichment | SLC17A8 | 0.76 |
| 390 | Strabismus | Enrichment | SLC2A1 | 0.75 |
| 391 | Microcephaly | Enrichment | NUP188, PSMC3, SLC2A1 | 0.73 |
| 392 | Alzheimer disease, familial, 1 | Enrichment | VCP | 0.73 |
| 393 | Pancreatitis, hereditary | Enrichment | CFTR | 0.73 |
| 394 | Interstitial lung disease 2 | Enrichment | ABCA3 | 0.73 |
| 395 | Autism spectrum disorder | Enrichment | HK1, SLC3A1 | 0.73 |
| 396 | Differentiated thyroid carcinoma | Enrichment | TPR | 0.72 |
| 397 | Patent foramen ovale | Enrichment | PSMC3 | 0.71 |
| 398 | Long qt syndrome 1 | Enrichment | SLC2A2 | 0.71 |
| 399 | Lung cancer | Enrichment | SLC67A1 | 0.68 |
| 400 | Primary autosomal recessive microcephaly | Enrichment | NUP37 | 0.68 |
| 401 | Connective tissue disease | Enrichment | SLC26A2 | 0.68 |
| 402 | Peripheral nervous system disease | Enrichment | SLC12A6 | 0.68 |
| 403 | Neuropathy | Enrichment | SLC12A6 | 0.68 |
| 404 | Macs syndrome | Enrichment | ABCB6 | 0.67 |
| 405 | Breast cancer | Enrichment | ABCA1, SLC67A1 | 0.64 |
| 406 | Myocardial infarction | Enrichment | PSMA6 | 0.63 |
| 407 | Skin disease | Enrichment | ABCA12 | 0.63 |
| 408 | Fetal akinesia deformation sequence 1 | Enrichment | NUP88 | 0.63 |
| 409 | Leukemia, acute myeloid | Enrichment | NUP214 | 0.60 |
| 410 | Epilepsy | Enrichment | SLC2A1 | 0.60 |
| 411 | Benign epilepsy with centrotemporal spikes | Enrichment | SLC2A1 | 0.59 |
| 412 | Centralopathic epilepsy | Enrichment | SLC2A1 | 0.57 |
| 413 | Nephrotic syndrome | Enrichment | NUP93 | 0.57 |
| 414 | Brugada syndrome | Enrichment | ABCC9 | 0.57 |
| 415 | West syndrome | Enrichment | SLC2A1 | 0.56 |
| 416 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | SLC2A10 | 0.56 |
| 417 | Hereditary breast carcinoma | Enrichment | SLC67A1 | 0.56 |
| 418 | Sensorineural hearing loss | Enrichment | SLC26A4 | 0.53 |
| 419 | Body mass index quantitative trait locus 11 | Enrichment | SLC6A14 | 0.52 |
| 420 | Hypertelorism | Enrichment | SLC12A6 | 0.50 |
| 421 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | SLC17A8 | 0.50 |
| 422 | Short-rib thoracic dysplasia 1 with or without polydactyly | Enrichment | ABCG5 | 0.48 |
| 423 | Hereditary breast ovarian cancer syndrome | Enrichment | SLC34A2 | 0.48 |
| 424 | Male infertility | Enrichment | CFTR | 0.47 |
| 425 | Autosomal recessive non-syndromic intellectual disability | Enrichment | TPR | 0.46 |
| 426 | Eye disease | Enrichment | ABCC6 | 0.46 |
| 427 | Deafness, autosomal recessive | Enrichment | SLC26A4 | 0.43 |
| 428 | Autosomal recessive nonsyndromic deafness | Enrichment | SLC26A4 | 0.43 |
| 429 | Optic atrophy plus syndrome | Enrichment | ABCC6 | 0.38 |
| 430 | Rare genetic deafness | Enrichment | SLC26A4 | 0.36 |
| 431 | Retinitis pigmentosa | Enrichment | HK1, SLC24A1 | 0.34 |
| 432 | Colorectal cancer | Enrichment | SLC9A9 | 0.33 |
| 433 | Familial isolated dilated cardiomyopathy | Enrichment | ABCC9 | 0.32 |
| 434 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | SLC26A4 | 0.32 |
| 435 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | CFTR | 0.31 |
| 436 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | VCP | 0.30 |
| 437 | Hereditary retinal dystrophy | Enrichment | HK1, SLC24A1 | 0.21 |
| 438 | Fundus dystrophy | Enrichment | HK1, SLC24A1 | 0.21 |
| 439 | Complex neurodevelopmental disorder | Enrichment | PSMD12 | 0.11 |